Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy

Michael J Brumlik Assistant Professor of Medicine University of Texas Health Sciences Center at San Antonio, San Antonio Cancer Institute, 2040 Babcock Road, Suite 201, San Antonio, TX 78229, USA +1 210 562 5276; +1 210 562 5292; [email protected]

, PhD,

Benjamin J Daniel Instructor of Medicine University of Texas Health Sciences Center at San Antonio, San Antonio Cancer Institute, 2040 Babcock Road, Suite 201, San Antonio, TX 78229, USA

, PhD,

Reinhard Waehler Postdoctoral Fellow The University of Alabama at Birmingham, Division of Human Gene Therapy, 901 19th Street South, Birmingham, AL 35294, USA

, Phd,

David T Curiel Professor of Medicine, Director of the Division of Human Gene Therapy, Director of the Gene Therapy Center The University of Alabama at Birmingham, Division of Human Gene Therapy, 901 19th Street South, Birmingham, AL 35294, USA

, MD PhD,

Francis J Giles Professor of Medicine, Chief of the Division of Hematology and Medical Oncology, Director of Experimental Therapeutics, San Antonio Cancer Institute, University of Texas Health Sciences Center at San Antonio, 2040 Babcock Road, Suite 201, San Antonio, TX 78229 Director, Institute for Drug Development, Cancer Therapy & Research Center, 7373 Wurzbach Road, San Antonio 78229, USA

, MB MD FRCPI FRCPath &

Tyler J Curiel

, MD MPH

Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date